IL17A and neoplasm: Published studies have demonstrated that tumor-associated TGF-β not only suppresses NK cell activity and T-cell mediated anti-tumor responses, but also actively subverts the CD8+ arm of the immune system into directly promoting tumor growth by an IL-17-dependent mechanism [48,49,52-54].